NCT00285077 Long-Term Safety Extension With SR57667B in Patients With Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT00285025 Study of the Effect of SR57667B in Patients With Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT00284141 Study of AVE0005 (VEGF Trap) in Locally Advanced or Metastatic Platinum- and Erlotinib- Resistant Non-small-cell-lung Adenocarcinoma Status COMPLETED Phase PHASE2
NCT00284128 AVE7688 in Patients With Mild to Moderate Blood Pressure Status COMPLETED Phase PHASE2/PHASE3
NCT00283829 Immunotherapy After Chemotherapy for Patients With Hormone Refractory Metastatic Prostate Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00283790 Residual Effects of Zolpidem Tartrate Extended Release and Eszopiclone Vs Placebo Status COMPLETED Phase PHASE4
NCT00283062 Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical Prostatectomy Status COMPLETED Phase PHASE3
NCT00283049 Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory Control Status TERMINATED Phase PHASE4
NCT00280098 Docetaxel in the Treatment of Hormone Refractory Prostate Cancer Status COMPLETED Phase PHASE4
NCT00275210 MOSAIC - Multicenter International Study of Oxaliplatin/ 5FU-LV in the Adjuvant Treatment of Colon Cancer Status COMPLETED Phase PHASE3
NCT00273546 Induction Chemotherapy Comparing Taxotere® Cisplatin and 5-Fluorouracil (TPF) With Standard Cisplatin and 5-Fluorouracil (PF) Followed by Chemoradiation in Locally Advanced Head and Neck Cancer Status COMPLETED Phase PHASE3